These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 10464669)

  • 1. Screening Jews and genes: a consideration of the ethics of genetic screening within the Jewish community: challenges and responses.
    Levin M
    Genet Test; 1999; 3(2):207-13. PubMed ID: 10464669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Tay-Sachs disease screening program in the U.S. as a model for the control of genetic disease: an historical view.
    Edelson PJ
    Health Matrix Clevel; 1997; 7(1):125-33. PubMed ID: 10167171
    [No Abstract]   [Full Text] [Related]  

  • 3. The ovrselling of genetic anxiety.
    Goodman MJ; Goodman LE
    Hastings Cent Rep; 1982 Oct; 12(5):20-7. PubMed ID: 7174291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for genetic disorders among Jews: how should the Tay-Sachs screening program be continued?
    Zlotogora J; Leventhal A
    Isr Med Assoc J; 2000 Sep; 2(9):665-7. PubMed ID: 11062764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethical Issues with Genetic Testing for Tay-Sachs.
    Clayton T
    J Christ Nurs; 2017; 34(4):246-249. PubMed ID: 28902054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for carriers of Tay-Sachs disease in the ultraorthodox Ashkenazi Jewish community in Israel.
    Broide E; Zeigler M; Eckstein J; Bach G
    Am J Med Genet; 1993 Aug; 47(2):213-5. PubMed ID: 8213907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The frequency of Tay-Sachs disease causing mutations in the Brazilian Jewish population justifies a carrier screening program.
    Rozenberg R; Pereira Lda V
    Sao Paulo Med J; 2001 Jul; 119(4):146-9. PubMed ID: 11500789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal testing for Tay-Sachs disease in the light of Jewish views regarding abortion.
    Baskin J
    Issues Health Care Women; 1983; 4(1):41-56. PubMed ID: 6553058
    [No Abstract]   [Full Text] [Related]  

  • 9. Screening for Tay-Sachs disease: a note of caution.
    Rosner F
    J Clin Ethics; 1991; 2(4):251-2. PubMed ID: 1804394
    [No Abstract]   [Full Text] [Related]  

  • 10. Tay Sachs disease in Australia: reduced disease incidence despite stable carrier frequency in Australian Jews.
    Lew RM; Proos AL; Burnett L; Delatycki M; Bankier A; Fietz MJ
    Med J Aust; 2012 Dec; 197(11):652-4. PubMed ID: 23230938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carrier screening for genetic disorders in individuals of Ashkenazi Jewish descent.
    Langlois S; Wilson RD; ;
    J Obstet Gynaecol Can; 2006 Apr; 28(4):324-332. PubMed ID: 16776912
    [No Abstract]   [Full Text] [Related]  

  • 12. Tay-Sachs disease: knowledge and attitudes of the rabbinical community.
    Abuelo DN; Rosenstein J; Sheff M
    R I Med J (1976); 1985 May; 68(5):225-6. PubMed ID: 3859903
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of the physician in screening for carriers of Tay-Sachs disease.
    Lowden JA
    Can Med Assoc J; 1978 Sep; 119(6):575-8. PubMed ID: 709448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Biochemical, molecular and social aspects of carrier screening for Tay-Sachs disease].
    Peleg L; Gazit E; Goldman B; Akstein E
    Harefuah; 1995 Dec; 129(11):475-80. PubMed ID: 8846957
    [No Abstract]   [Full Text] [Related]  

  • 15. Screening and prevention in Tay-Sachs disease: origins, update, and impact.
    Kaback MM
    Adv Genet; 2001; 44():253-65. PubMed ID: 11596988
    [No Abstract]   [Full Text] [Related]  

  • 16. Ashkenazi Jewish population screening for Tay-Sachs disease: the international and Australian experience.
    Lew RM; Burnett L; Proos AL; Barlow-Stewart K; Delatycki MB; Bankier A; Aizenberg H; Field MJ; Berman Y; Fleischer R; Fietz M
    J Paediatr Child Health; 2015 Mar; 51(3):271-9. PubMed ID: 24923490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Euthanasia: an overview and the jewish perspective.
    Gesundheit B; Steinberg A; Glick S; Or R; Jotkovitz A
    Cancer Invest; 2006 Oct; 24(6):621-9. PubMed ID: 16982468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tay-Sachs disease carrier screening: a 21-year experience.
    D'Souza G; McCann CL; Hedrick J; Fairley C; Nagel HL; Kushner JD; Kessel R
    Genet Test; 2000; 4(3):257-63. PubMed ID: 11142756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ashkenazi Jewish genetic disorders.
    Charrow J
    Fam Cancer; 2004; 3(3-4):201-6. PubMed ID: 15516842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The control of genetic disease by carrier screening and antenatal diagnosis: social, ethical, and medicolegal issues.
    Kaback MM
    Birth Defects Orig Artic Ser; 1982; 18(7):243-54. PubMed ID: 7159734
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.